Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.
2 reports, 1 independent
Updated Aug 14
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Clover Health
U.S. healthcare company
-
Scott Bessent
United States Secretary of the Treasury
-
Surgery Partners
healthcare services company
-
Illumina
American company that develops systems for the analysis of genetic variation
Nothing else this week.
Coverage
Newest first; wire copies grouped- StockStoryClover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know A number of stocks jumped in the afternoon session after markets continued to r
- StockStorySGRY Q2 Deep Dive: Orthopedics and De Novo Expansion Drive Steady Growth Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% yea